Blue Jet Healthcare Ltd
BLUEJET
Company Profile
Business description
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients. Geographically, it operates in Norway, France, India and Rest of the World.
Contact
701, 702, 7th Floor, Plot No. 1 & 2
Bhumiraj Costarica, Sector 18
Sanpada
Navi MumbaiMH400 705
INDT: +91 2222075307
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 March 2026
Employees
491
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,324.60 | 40.80 | 0.44% |
| CAC 40 | 8,189.49 | 15.29 | 0.19% |
| DAX 40 | 24,208.65 | 377.66 | 1.58% |
| Dow JONES (US) | 46,396.40 | 205.79 | 0.45% |
| FTSE 100 | 9,400.59 | 46.02 | 0.49% |
| HKSE | 25,858.83 | 611.73 | 2.42% |
| NASDAQ | 22,851.45 | 171.47 | 0.76% |
| Nikkei 225 | 49,185.50 | 1,603.35 | 3.37% |
| NZX 50 Index | 13,344.96 | 55.75 | 0.42% |
| S&P 500 | 6,703.42 | 39.41 | 0.59% |
| S&P/ASX 200 | 9,031.90 | 43.70 | 0.49% |
| SSE Composite Index | 3,863.89 | 24.14 | 0.63% |